Biofrontera Inc

BFRI04 Dec 2024
Healthcare
$0.96
+0.10 (+10.03%)
Lowest Today
$0.94
Highest Today
$1.03
Today’s Open
$0.96
Prev. Close
$0.94
52 Week High
$4
52 Week Low
$0.61
To Invest in Biofrontera Inc

Biofrontera Inc

Healthcare
BFRI04 Dec 2024
+0.10 (+10.03%)
1M
3M
6M
1Y
5Y
Low
$0.94
Day’s Range
High
$1.03
0.94
52 Week Low
$0.61
52-Week Range
52 Week High
$4
0.61
1 Day
-
1 Week
-3.09%
1 month return
-7.76%
3 month return
-17.39%
6 month return
-7.76%
1 Year return
-74.32%
3 Years return
-98.87%
5 Years return
-
10 Years return
-
Institutional Holdings
AIGH Capital Management, LLC
6.47
Rosalind Advisors, Inc.
6.39
Scotia Capital Inc
0.65
Geode Capital Management, LLC
0.22
Fidelity Extended Market Index
0.2
Vanguard Institutional Extnd Mkt Idx Tr
0.11
BlackRock Inc
0.06

Market Status

Fundamentals
Market Cap
7.75 mln
PB Ratio
1.4
PE Ratio
0.86
Enterprise Value
5.86 mln
Total Assets
27.93 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Organisation
Biofrontera Inc
Employees
83
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Hermann  Luebbert Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step